Taichung Veterans General Hospital
Taichung, 40705, Taiwan
Location status: Recruiting
Location contact
Jing-Jie Wang, MD
CONTACT
+886(4)23592525 ext. 5401
Rong-San Jiang, MD, PhD
CONTACT
+886(4)23592525 ext. 4000
NCT Number: NCT07340411
Investigators tried to evaluate the efficacy and safety of Chinese herbal medicine nasal irrigation as an adjuvant therapy after FESS.
Interested in participating?
Request Info18 year–90 year
All sexes
Interventional
Phase 2
Taichung, 40705, Taiwan
Location status: Recruiting
Jing-Jie Wang, MD
CONTACT
+886(4)23592525 ext. 5401
Rong-San Jiang, MD, PhD
CONTACT
+886(4)23592525 ext. 4000
In this study, patients with chronic rhinosinusitis who received FESS were recruited and randomly assigned to 2 groups at one month post-surgery. Patients in the xylitol group received 240ml of Chinese herbal medicine nasal irrigation daily for 2 months, and those in the normal saline (NS) group received 240ml of NS nasal irrigation daily for 2 months. Before FESS as well as before and after nasal irrigation, sino-nasal symptoms were assessed by a 22-item Sino-Nasal Outcome Test questionnaire and patients received endoscopic examination, nasal function tests, cytokine measurement of nasal irrigant, and bacterial culture from the middle meatus. The safety of nasal irrigation was assessed by self-reported adverse events, and blood test. This study tried to evaluate the efficacy and safety of Chinese herbal medicine nasal irrigation as an adjuvant therapy after FESS.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The bilateral nasal cavity was irrigated by using a NeilMed® SINUS RINSE™ Squeeze Bottle containing 240ml of Chinese herbal medicine solution twice a day for 2 months.
Other names: 2 gram of SHIN YI CHING FEY TANG, 0.5 gram of chrysanthemum, and 0.125 gram of Borneo camphor
The bilateral nasal cavity was irrigated by using a NeilMed® SINUS RINSE™ Squeeze Bottle containing 240ml of of normal saline twice a day for 2 months.
Time frame: From before operation to 3 months after surgery
The Taiwanese version of the 22-item Sino-Nasal Outcome Test contains 22 items of symptoms and social/emotional consequences from nasal disorder. Patients are asked to rate their problems based on how they have been over the past two weeks. Each item is graded from 0 (no problem) to 5 (as bad as it can be) according to its severity and frequency.
Time frame: From before nasal irrigation to after 2-month nasal irrigation
Any adverse events occurring during the 2 months period of nasal irrigation
Time frame: From before operation to 3 months after surgery
The second minimal cross-sectional area of the nasal cavity was measured by acoustic rhinometry.
Time frame: From before operation to 3 months after surgery
The endoscopic appearances were categorized into polyps (0: no polyps; 1: polyps present within the middle meatus; 2: polyps beyond the middle meatus); nasal secretion (0: no secretion; 1: clear, thin secretion; 2: thick, purulent secretion); mucosal edema; scarring; crusting; (0: absent; 1: mild; 2: severe). The score ranged from 0 to 20 for both nostrils together.
Time frame: From before operation to 3 months after surgery
The saccharine transit test involved placing saccharine granules under the head of the inferior turbinate in the more severely affected nostril. The time interval (minute) between placement of saccharine granules and sensation of sweetness in the throat was recorded.
Contact information is provided by the study sponsor or research team.
Taichung Veterans General Hospital
Other
Acronym: Breeze Clear
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06108921
Chronic Rhinosinusitis, Postoperative Care
Taichung, None Selected, Taiwan
View Trial DetailsNCT05935683
Chronic Rhinosinusitis, Disease
Rozzano, MIlan, Italy
View Trial DetailsNCT07470242
Chronic Rhinosinusitis
Pusan, South Korea
View Trial DetailsNCT04117646
Chronic Rhinosinusitis, Fistula
Paris, France
View Trial Details